Physician profile
Gregory Evans
NPI 1154344968
$1,202.30
in general payments reported to CMS, 2019-2025
14 companies · $16.10 in 2025
The $16.10 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $275 · 2021: $406 · 2022: $152 · 2025: $16.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $411.97 | 2019-2022 | |
| Janssen Biotech, INC. | $262.67 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $122.52 | 2019-2020 | |
| Abbvie INC. | $115.87 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $101.23 | 2019-2022 | |
| Novo Nordisk INC | $45.41 | 2020 | |
| Tepha INC | $29.26 | 2019 | |
| Integra Lifesciences Corporation | $24.75 | 2021 | |
| Theratechnologies INC. | $16.29 | 2022 | |
| Glaxosmithkline, LLC. | $16.10 | 2025 | Bexsero |
| Otsuka America Pharmaceutical, INC. | $15.03 | 2022 | |
| Viiv Healthcare Company | $14.93 | 2022 | |
| Bausch Health US, LLC | $14.08 | 2020 | |
| Allergan, INC. | $12.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.